CURRADO, DAMIANO
 Distribuzione geografica
Continente #
AS - Asia 814
NA - Nord America 146
EU - Europa 118
SA - Sud America 7
AF - Africa 2
OC - Oceania 1
Totale 1.088
Nazione #
SG - Singapore 685
US - Stati Uniti d'America 141
CN - Cina 62
HK - Hong Kong 48
IT - Italia 34
GB - Regno Unito 29
NL - Olanda 19
DE - Germania 12
TR - Turchia 11
FI - Finlandia 9
BR - Brasile 7
CA - Canada 5
IN - India 4
FR - Francia 3
PL - Polonia 3
UA - Ucraina 3
AT - Austria 2
EE - Estonia 2
JP - Giappone 2
ZA - Sudafrica 2
AU - Australia 1
ID - Indonesia 1
IL - Israele 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 1.088
Città #
Singapore 69
Hong Kong 48
Ashburn 34
Boardman 29
Hefei 29
London 26
Amsterdam 17
Shanghai 17
Rome 13
Ankara 11
Council Bluffs 11
West Jordan 8
Jaguariúna 7
Helsinki 5
Las Vegas 5
Munich 5
Los Angeles 3
Milan 3
Paris 3
Pune 3
Secaucus 3
Turku 3
Warsaw 3
Washington 3
Beijing 2
Hangzhou 2
Herne Bay 2
Jinan 2
Montreal 2
Narashino Shi 2
Santa Clara 2
Seattle 2
Toronto 2
Belgrade 1
Bourne 1
Brooklyn 1
Changsha 1
Chennai 1
Chicago 1
Haikou 1
Krasnoyarsk 1
Lecce 1
Luoyang 1
L’Aquila 1
Markham 1
Melbourne 1
Nanchang 1
Newark 1
Parma 1
San Francisco 1
Siena 1
St Louis 1
Tel Aviv 1
Vienna 1
Totale 397
Nome #
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 152
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 136
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 106
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 79
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 72
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 66
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 55
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 50
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 44
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 39
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 32
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 30
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 23
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 19
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 18
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 18
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 17
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 17
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 17
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 16
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 16
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 15
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 15
Secukinumab-induced subacute cutaneous lupus erythematosus 14
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 14
Euthymic despite pain: the role of cognitive reappraisal and experiential avoidance in autoimmune inflammatory rheumatic diseases—a cross-sectional study 6
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 6
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort 5
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 5
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis 4
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 4
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 3
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 2
From pain catastrophising to multidimensional psychological distress: unravelling the complexity of difficult-to-treat psoriatic arthritis 2
Totale 1.117
Categoria #
all - tutte 7.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 1 0 0 0 0 1 0 3 0 0 16
2022/202336 0 0 0 1 11 0 4 0 1 1 14 4
2023/2024100 3 9 3 12 14 31 5 2 2 8 11 0
2024/2025960 10 18 33 32 27 31 22 7 76 84 295 325
Totale 1.117